BE513350A - - Google Patents
Info
- Publication number
- BE513350A BE513350A BE513350DA BE513350A BE 513350 A BE513350 A BE 513350A BE 513350D A BE513350D A BE 513350DA BE 513350 A BE513350 A BE 513350A
- Authority
- BE
- Belgium
- Prior art keywords
- acid
- salt
- ester
- water
- aminosalicylic
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 claims description 51
- 239000002253 acid Substances 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 29
- WUBBRNOQWQTFEX-UHFFFAOYSA-N 4-aminosalicylic acid Chemical compound NC1=CC=C(C(O)=O)C(O)=C1 WUBBRNOQWQTFEX-UHFFFAOYSA-N 0.000 claims description 15
- 229960004909 aminosalicylic acid Drugs 0.000 claims description 15
- 150000002148 esters Chemical class 0.000 claims description 14
- 238000002844 melting Methods 0.000 claims description 12
- 230000008018 melting Effects 0.000 claims description 12
- 150000007524 organic acids Chemical class 0.000 claims description 12
- 235000005985 organic acids Nutrition 0.000 claims description 7
- 229910052757 nitrogen Inorganic materials 0.000 claims description 5
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 5
- 239000003960 organic solvent Substances 0.000 claims description 5
- NBGAYCYFNGPNPV-UHFFFAOYSA-N 2-aminooxybenzoic acid Chemical class NOC1=CC=CC=C1C(O)=O NBGAYCYFNGPNPV-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- -1 piperidinoethyl ester Chemical class 0.000 description 23
- 235000019441 ethanol Nutrition 0.000 description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 14
- 239000000243 solution Substances 0.000 description 10
- 150000001298 alcohols Chemical class 0.000 description 8
- 238000001704 evaporation Methods 0.000 description 5
- 230000008020 evaporation Effects 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- GHSCYMOJHVOGDJ-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-amino-2-hydroxybenzoate Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1O GHSCYMOJHVOGDJ-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- RWZYAGGXGHYGMB-UHFFFAOYSA-N anthranilic acid Chemical compound NC1=CC=CC=C1C(O)=O RWZYAGGXGHYGMB-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 4
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 4
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 4
- ZAJAQTYSTDTMCU-UHFFFAOYSA-N 3-aminobenzenesulfonic acid Chemical compound NC1=CC=CC(S(O)(=O)=O)=C1 ZAJAQTYSTDTMCU-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000003589 local anesthetic agent Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 201000008827 tuberculosis Diseases 0.000 description 3
- IGLFNZTYROTIGK-UHFFFAOYSA-N 2-(diethylamino)ethyl 3-amino-2-hydroxybenzoate Chemical compound CCN(CC)CCOC(=O)C1=CC=CC(N)=C1O IGLFNZTYROTIGK-UHFFFAOYSA-N 0.000 description 2
- DYMQZBNGFSKNPG-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-(butylamino)-2-hydroxybenzoate Chemical compound CCCCNC1=CC=C(C(=O)OCCN(CC)CC)C(O)=C1 DYMQZBNGFSKNPG-UHFFFAOYSA-N 0.000 description 2
- WRRFQBAFSMEJDJ-UHFFFAOYSA-N 2-(diethylamino)ethyl 5-amino-2-hydroxybenzoate Chemical compound C(C)N(CC)CCOC(C1=C(C=CC(=C1)N)O)=O WRRFQBAFSMEJDJ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 230000001588 bifunctional effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 229960001270 d- tartaric acid Drugs 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- ZJXZSIYSNXKHEA-UHFFFAOYSA-N ethyl dihydrogen phosphate Chemical compound CCOP(O)(O)=O ZJXZSIYSNXKHEA-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 229940045996 isethionic acid Drugs 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- KBOPZPXVLCULAV-UHFFFAOYSA-N mesalamine Chemical compound NC1=CC=C(O)C(C(O)=O)=C1 KBOPZPXVLCULAV-UHFFFAOYSA-N 0.000 description 2
- 229960004963 mesalazine Drugs 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- XSWWQZPGJLCCOH-UHFFFAOYSA-N 2-(diethylamino)ethyl 2-hydroxy-4-(propan-2-ylamino)benzoate Chemical compound C(C)(C)NC1=CC(=C(C(=O)OCCN(CC)CC)C=C1)O XSWWQZPGJLCCOH-UHFFFAOYSA-N 0.000 description 1
- JHYVOYPJWUFGKV-UHFFFAOYSA-N 2-(diethylamino)ethyl 4-(butylamino)-2-hydroxybenzoate;hydrochloride Chemical compound [Cl-].CCCCNC1=CC=C(C(=O)OCC[NH+](CC)CC)C(O)=C1 JHYVOYPJWUFGKV-UHFFFAOYSA-N 0.000 description 1
- BVSFSNFSSNBBRH-UHFFFAOYSA-N 2-(dimethylamino)ethyl 4-amino-2-hydroxybenzoate Chemical compound CN(C)CCOC(=O)C1=CC=C(N)C=C1O BVSFSNFSSNBBRH-UHFFFAOYSA-N 0.000 description 1
- UHVFCHSLHAXDPS-UHFFFAOYSA-N 2-hydroxy-4-(propylamino)benzoic acid Chemical compound CCCNC1=CC=C(C(O)=O)C(O)=C1 UHVFCHSLHAXDPS-UHFFFAOYSA-N 0.000 description 1
- SZTACZQBDGBPKG-UHFFFAOYSA-N 2-hydroxy-5-(propylamino)benzoic acid Chemical compound CCCNC1=CC=C(O)C(C(O)=O)=C1 SZTACZQBDGBPKG-UHFFFAOYSA-N 0.000 description 1
- UHYQLNYSTRFRRF-UHFFFAOYSA-N 2-piperidin-1-ylethyl 4-amino-2-hydroxybenzoate Chemical compound N1(CCCCC1)CCOC(C1=C(C=C(C=C1)N)O)=O UHYQLNYSTRFRRF-UHFFFAOYSA-N 0.000 description 1
- IQGMRVWUTCYCST-UHFFFAOYSA-N 3-Aminosalicylic acid Chemical compound NC1=CC=CC(C(O)=O)=C1O IQGMRVWUTCYCST-UHFFFAOYSA-N 0.000 description 1
- FEEAGCZFKJMNDK-UHFFFAOYSA-N 4-(butylamino)-2-hydroxybenzoic acid Chemical compound CCCCNC1=CC=C(C(O)=O)C(O)=C1 FEEAGCZFKJMNDK-UHFFFAOYSA-N 0.000 description 1
- YCCRFDDXAVMSLM-UHFFFAOYSA-N 4-(butylamino)benzoic acid Chemical compound CCCCNC1=CC=C(C(O)=O)C=C1 YCCRFDDXAVMSLM-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- GTCZFOKUGWSLLG-UHFFFAOYSA-N OS([P])(=O)=O Chemical class OS([P])(=O)=O GTCZFOKUGWSLLG-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical group C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 229960004050 aminobenzoic acid Drugs 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 230000000973 chemotherapeutic effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- DHCUQNSUUYMFGX-UHFFFAOYSA-N hydroxytetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C(O)=C1 DHCUQNSUUYMFGX-UHFFFAOYSA-N 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 125000000587 piperidin-1-yl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000003460 sulfonic acids Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE513350A true BE513350A (d) |
Family
ID=151507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE513350D BE513350A (d) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE513350A (d) |
-
0
- BE BE513350D patent/BE513350A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE513350A (d) | ||
| CA1276644C (fr) | Benzamides, leur procede de preparation et leur application dans le domaine therapeutique | |
| CA1098911A (fr) | N-(1'-ethyl 2'-oxo 5'-pyrrolidinyl methyl) benzamides leurs procedes de preparation et leur application comme modificateurs du comportement | |
| BE428575A (d) | ||
| BE571750A (d) | ||
| BE521436A (d) | ||
| BE557074A (d) | ||
| EP0022022A1 (fr) | Nouveaux dérivés acylés de la taurine et leurs sels et procédé pour leur préparation | |
| BE493864A (d) | ||
| BE557293A (d) | ||
| BE504017A (d) | ||
| BE517656A (d) | ||
| BE533436A (d) | ||
| BE528126A (d) | ||
| BE636257A (d) | ||
| BE479227A (d) | ||
| BE492297A (d) | ||
| BE459304A (d) | ||
| BE539242A (d) | ||
| CH338197A (fr) | Procédé d'obtention de peptides | |
| BE567876A (d) | ||
| BE492921A (d) | ||
| BE425248A (d) | ||
| BE571404A (d) | ||
| CH622252A5 (en) | Process for the preparation of new 1-nitrophenyl-1H,3H-quinazoline-2,4-diones |